BIOSCRIP INC's ticker is BIOSXXXX and the CUSIP is 09069N108. A total of 141 filers reported holding BIOSCRIP INC in Q2 2014. The put-call ratio across all filers is 4.58 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $0 | -100.0% | 200 | 0.0% | 0.00% | – |
| Q4 2017 | $1,000 | -98.5% | 200 | -97.9% | 0.00% | -100.0% |
| Q3 2014 | $65,000 | -12.2% | 9,400 | +5.6% | 0.03% | -5.7% |
| Q2 2014 | $74,000 | +64.4% | 8,900 | +39.1% | 0.04% | +150.0% |
| Q1 2014 | $45,000 | 0.0% | 6,400 | +4.9% | 0.01% | -12.5% |
| Q4 2013 | $45,000 | +542.9% | 6,100 | +662.5% | 0.02% | +433.3% |
| Q3 2013 | $7,000 | – | 800 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Venor Capital Management LP | 12,005,453 | $20,409,000 | 10.92% |
| Coliseum Capital Management, LLC | 5,622,410 | $9,558,000 | 4.30% |
| Alta Fundamental Advisers LLC | 2,217,164 | $3,769,000 | 4.07% |
| WYNNEFIELD CAPITAL INC | 3,800,000 | $6,460,000 | 2.37% |
| ARDSLEY ADVISORY PARTNERS LP | 5,280,000 | $8,976,000 | 1.40% |
| NORTH TIDE CAPITAL, LLC | 3,000,000 | $5,100,000 | 0.78% |
| Camber Capital Management LP | 10,180,000 | $17,306,000 | 0.70% |
| PERKINS CAPITAL MANAGEMENT INC | 310,500 | $528,000 | 0.54% |
| ROANOKE ASSET MANAGEMENT CORP/ NY | 233,280 | $397,000 | 0.19% |
| Eidelman Virant Capital | 140,000 | $238,000 | 0.16% |